Can Fite Biopharma Ltd.-ADRCANF
13F holders, Q2 2026 (June 30)8holders −6
0new positions
6sold out
1famous investor
$2.97avg. 13F price*
At the end of Q2 2026, 8 institutions reported holding Can Fite Biopharma Ltd.-ADR (CANF) in their 13F filings, down 6 from Q1 2026. 0 opened new positions and 6 sold out. The largest holders were Citadel Advisors ($97K), Rhumbline Advisers ($52K) and Fifth Third Bancorp ($446). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Can Fite Biopharma Ltd.-ADR
- CUSIP
- 13471N409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 6 | $257K |
All 13F filers, Q1 2026 → Q2 2026: 88,092 shares sold, net −88,092 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Citadel Advisors | 0.00% | Reduce -4.7% | 32,533 | $97K |
| Rhumbline Advisers | 0.00% | Reduce -16.6% | 17,433 | $52K |
| Fifth Third Bancorp | 0.00% | No change | 150 | $446 |
| Wells Fargo & Company | 0.00% | Reduce -52.8% | 59 | $175 |
| Activest Wealth Management | 0.00% | No change | 10 | $30 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $4 |
| Morgan Stanley | 0.00% | No change | 1 | $3 |
| Avion Wealth | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is CANF's weight in each manager's 13F, not the share of Can Fite Biopharma Ltd.-ADR the manager owns.